Chang, Julia W, Ph.D.

Research

Characterizing the molecular mechanisms underlying pharmacoresistant infantile epilepsy

Appointments

• Assistant Researcher

Publications

1. Min, S, Chang, JW. From Past to Present: The Evolution of Pharmacologic Therapies for Eosinophilic Esophagitis. Gastroenterol Hepatol (N Y). 2025;21 (5):298-303. . PubMed PMID:40416916 PubMed Central PMC12100528.
2. Liu, L, Oh, C, Lim, MA, Zheng, S, Piao, Y, Ohm, S et al.. Dual blockage of P-cadherin and c-Met synergistically inhibits the growth of head and neck cancer. Cell Oncol (Dordr). 2025; :. doi: 10.1007/s13402-025-01061-w. PubMed PMID:40392501 .
3. Chang, JW, Ngabonziza, D, Deweese, J. Plasmid DNA Binding Electrophoretic Mobility Shift Assay with Eukaryotic Topoisomerase II. Methods Mol Biol. 2025;2928 :109-114. doi: 10.1007/978-1-0716-4550-5_10. PubMed PMID:40372641 .
4. Wang, M, Krueger, JB, Gilkey, AK, Stelljes, EM, Kluesner, MG, Pomeroy, EJ et al.. Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing. J Immunother Cancer. 2025;13 (5):. doi: 10.1136/jitc-2024-009560. PubMed PMID:40341025 PubMed Central PMC12067936.
5. Chang, JW, O'Brian, AK, Thomas, AJ, Hardin, MR, Latham, BD, Ngabonziza, D et al.. Mutagenesis of Intrinsically Disordered Domain Impacts Topoisomerase IIα Catalytic Activity. Int J Mol Sci. 2025;26 (8):. doi: 10.3390/ijms26083604. PubMed PMID:40332112 PubMed Central PMC12026768.

Search PubMed